213 filings
8-K
MREO
Mereo Biopharma Group Plc
23 May 24
Submission of Matters to a Vote of Security Holders
4:16pm
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
8-K
MREO
Mereo Biopharma Group Plc
15 May 24
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
ARS
2023 FY
MREO
Mereo Biopharma Group Plc
24 Apr 24
Annual report to shareholders
7:36am
DEF 14A
j4i2f f2r71
24 Apr 24
Definitive proxy
7:30am
8-K
nb4kk2z 7kn
15 Apr 24
Entry into a Material Definitive Agreement
7:30am
10-K
nmvgtc rc
27 Mar 24
Annual report
5:20pm
8-K
3idzxd1 bg3by
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
S-8
02kssez5ejz
23 Jan 24
Registration of securities for employees
4:16pm
8-K
m2i3oy51tzvwm zu7pp
8 Jan 24
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
7:08am
8-A12B/A
fatyulx
18 Dec 23
Registration of securities on exchange (amended)
4:16pm
6-K
6an3bq8 eg43
18 Dec 23
Current report (foreign)
4:10pm
6-K
h3l6kjjpb3
29 Nov 23
Current report (foreign)
4:15pm
6-K
tzmug0fx21go
16 Nov 23
Current report (foreign)
7:01am
6-K
mu4cz
23 Oct 23
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
4:08pm
6-K
z2fxpr5tq
17 Oct 23
Current report (foreign)
7:01am
6-K
cmx mtop3jib3kutbnx1
20 Sep 23
Current report (foreign)
4:03pm
6-K
3l84pxc2k05f x6p2dk8
7 Sep 23
Current report (foreign)
7:37am
6-K
km4i8j35e46
6 Jul 23
Ultragenyx Announces First Patients Dosed in Phase 3 Program
8:05am